CompletedNot Applicable

The Effects of Soy Protein and Isoflavones on Glycemic Control, Insulin Sensitivity and Cardiovascular Risk Factors

Started 2007-10

Plain-language summary

The investigators propose to perform a double-blind, randomized placebo-controlled trial to examine the hypothesis that soy protein with isoflavones could improve glycemic control, insulin sensitivity and decrease cardiovascular risk factors in postmenopausal women with prediabetes.

Who can participate

Age range46 Years – 70 Years

SexFEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Hong Kong Chinese menopausal women aged 46-70 years with prediabetes or early untreated diabetes Exclusion Criteria: * Women with breast, ovary or other cancers in recent 5-year * Severe renal or liver dysfunction * Women with androgen excess * Smokers * Current use or recent (3-month)use of any drug or treatment for glycemic control, lipid improvement, weight reduction; Subjects with known soy or milk allergy.

Trial details

NCT IDNCT00856882

SponsorChinese University of Hong Kong

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2008-04

View on ClinicalTrials.gov More Diabetes trials